You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

donor lymphocytes infusion

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Allogeneic Stem Cell Transplant Candidate, Acute Myeloid/Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in Cleveland

Not yet recruiting
  • Allogeneic Stem Cell Transplant Candidate
  • +4 more
  • Cellular therapy product
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Jul 1, 2022

Immunodeficiency Trial in Charlotte (Infusion of donor lymphocytes)

Terminated
Has Results
  • Immunodeficiency
  • Infusion of donor lymphocytes
  • Charlotte, North Carolina
    Levine Children's Hospital, Carolinas Medical Center
Apr 20, 2022

MDS, Secondary Acute Myeloid Leukemia Trial in Tampa (CD8 Depleted, Non-engrafting,HLA mismatched unrelated donor lymphocytes,

Recruiting
  • Myelodysplastic Syndromes
  • Secondary Acute Myeloid Leukemia
  • CD8 Depleted, Non-engrafting,HLA mismatched unrelated donor lymphocytes
  • Standard of Care Chemotherapy
  • Tampa, Florida
    Moffitt Cancer Center
Sep 27, 2022

Bone Marrow Transplant Infection, Bone Marrow Transplant Complications, Graft Vs Host Disease Trial in Rozzano (modified donor

Completed
  • Bone Marrow Transplant Infection
  • +4 more
  • modified donor lymphocytes infusion (mDLI)
  • Rozzano, MI, Italy
    Istituto Clinico Humanitas
Dec 24, 2020

Hematologic Malignancy Trial in Saint Petersburg (Prophylactic Donor lymphocytes infusions, Preventive Donor lymphocytes

Recruiting
  • Hematologic Malignancy
  • Prophylactic Donor lymphocytes infusions
  • Preventive Donor lymphocytes infusions
  • Saint Petersburg, Russian Federation
    RM Gorbacheva Research Institute
Aug 16, 2021

Leukemia Trial in Badalona, Hospitalet de Llobregat, Barcelona (DLI of the 20 fraction of the UCBT)

Completed
  • Leukemia
  • DLI of the 20 fraction of the UCBT
  • Badalona, Barcelona, Spain
  • +4 more
Dec 3, 2021

CD19+ Malignancies: Relapse Post-allogeneic Transplant Trial in London (Infusion of modified CAR19 T-cells (4G7-CARD T-cells))

Active, not recruiting
  • CD19+ Malignancies: Relapse Post-allogeneic Transplant
  • Infusion of modified CAR19 T-cells (4G7-CARD T-cells)
  • London, United Kingdom
    University College London Hospital
Jun 16, 2021

Acute Myeloid Leukemia, High Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, in Relapse Trial in Moscow (boost

Recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • boost anti-viral immunity after T-cell depleted HSCT
  • Moscow, Russian Federation
    Federal Research Center for pediatric hematology, oncology and i
Oct 1, 2021

AML/MDS Trial in Copenhagen (iDLI)

Recruiting
  • AML/MDS
  • iDLI
  • Copenhagen, Denmark
    Copenhagen University Hospital, Rigshospitalet
Jan 13, 2023

CMV Viremia, CMV Trial in São Paulo (Lymphocyte infusion (ImmuneCellVir-I))

Recruiting
  • CMV Viremia
  • CMV
  • Lymphocyte infusion (ImmuneCellVir-I)
  • São Paulo, SP, Brazil
    Hospital Israelita Albert Einstein
Aug 21, 2023

Hematopoietic Organs; Disorder Trial in Hong Kong (CD62L depleted donor lymphocyte infusion)

Recruiting
  • Hematopoietic Organs; Disorder
  • CD62L depleted donor lymphocyte infusion
  • Hong Kong, Hong Kong
    Hong Kong Children's Hospital
Sep 6, 2023

Adenovirus Infection Trial in Columbus (Adenovirus Specific T lymphocytes)

Recruiting
  • Adenovirus Infection
  • Adenovirus Specific T lymphocytes
  • Columbus, Ohio
    Nationwide Children's Hospital
Sep 1, 2022

Hematologic Tumors Trial run by the NCI (donor lymphocyte infusion, Cyclophosphamide, Busulfan)

Suspended
  • Hematologic Neoplasms
  • donor lymphocyte infusion
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Nov 30, 2022

Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Cytomegalovirus, Donor Trial in Columbus (Allogeneic

Recruiting
  • Allogeneic Hematopoietic Stem Cell Transplantation Recipient
  • +3 more
  • Allogeneic Cytomegalovirus-Specific Cytotoxic T lymphocytes
  • Columbus, Ohio
  • +1 more
Apr 20, 2022

Hematologic Malignancy Trial in Tuebingen,, Tuebingen (CD45RA depleted donor lymphocyte infusion (DLI))

Recruiting
  • Hematologic Malignancy
  • CD45RA depleted donor lymphocyte infusion (DLI)
  • Tuebingen,, Germany
  • +1 more
Jul 13, 2023

Minimal Residual Disease, Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes, Recurrent Adult Acute Myeloid

Completed
  • Minimal Residual Disease
  • +3 more
  • Daratumumab
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Mar 2, 2022

Relapsed Adult ALL, Relapsed Adult AML Trial in Changchun (Plerixafor)

Active, not recruiting
  • Relapsed Adult ALL
  • Relapsed Adult AML
  • Changchun, Jilin, China
    First Hospital of Jilin University
Nov 19, 2023

Uveal Melanoma, Metastatic Cutaneous Melanoma Trial (Autologous Tumor Infiltrating Lymphocytes, Melphalan, Interleukin-2)

Not yet recruiting
  • Uveal Melanoma
  • Metastatic Cutaneous Melanoma
  • Autologous Tumor Infiltrating Lymphocytes
  • +2 more
  • (no location specified)
Jun 5, 2023

Metastatic Uveal Melanoma, Metastatic Cutaneous Melanoma Trial (Autologous Tumor Infiltrating Lymphocytes, Melphalan,

Not yet recruiting
  • Metastatic Uveal Melanoma
  • Metastatic Cutaneous Melanoma
  • Autologous Tumor Infiltrating Lymphocytes
  • +2 more
  • (no location specified)
Oct 14, 2022

Adenovirus, Primary Immune Deficiency Disorder Trial in United States (cytotoxic t-lymphocytes)

Recruiting
  • Adenovirus
  • Primary Immune Deficiency Disorder
  • cytotoxic t-lymphocytes
  • Los Angeles, California
  • +8 more
Sep 27, 2022

Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Buffalo (donor lymphocytes)

Completed
Has Results
  • Leukemia
  • +3 more
  • donor lymphocytes
  • Buffalo, New York
    Roswell Park Cancer Institute
Aug 21, 2020

Epstein-Barr Virus Infections, Primary Immune Deficiency Disorder Trial in United States (cytotoxic t-lymphocytes)

Recruiting
  • Epstein-Barr Virus Infections
  • Primary Immune Deficiency Disorder
  • cytotoxic t-lymphocytes
  • Los Angeles, California
  • +7 more
Sep 27, 2022

Leukemia Trial (Donor Enriched Activated Natural Killer Cell Infusion)

Withdrawn
  • Leukemia
  • Donor Enriched Activated Natural Killer Cell Infusion
  • (no location specified)
Dec 20, 2022

Living Donor Liver Transplantation Trial in Pittsburgh (Donor-derived DCreg)

Active, not recruiting
  • Living Donor Liver Transplantation
  • Donor-derived DCreg
  • Pittsburgh, Pennsylvania
    UPMC
Sep 7, 2022

Renal Failure Trial in Chicago, Louisville (Enriched Hematopoietic Stem Cell Infusion)

Active, not recruiting
  • Renal Failure
  • Enriched Hematopoietic Stem Cell Infusion
  • Chicago, Illinois
  • +1 more
Jul 15, 2022